Grapefruit juice-felodipine interaction: Effect of naringin and 6',7'- dihydroxybergamottin in humans

Clinical Pharmacology and Therapeutics

Volumn 64, Issue 3, 1998, Pages 248-256

  Bailey, David G ^a   Kreeft, John H ^b   Munoz, Claudio ^b   Freeman, David J ^b   Bend, John R ^b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 (2,3 DICHLOROPHENYL) 2,6 DIMETHYL 3,5 PYRIDINEDICARBOXYLIC ACID ETHYL METHYL ESTER; 6',7' DIHYDROXYBERGAMOTTIN; AURANTIIN; FELODIPINE; FUROCOUMARIN; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CENTRIFUGATION; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INHIBITION; FILTRATION; FOOD DRUG INTERACTION; FRUIT JUICE; HUMAN; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STRUCTURE ANALYSIS; SUSTAINED DRUG RELEASE;

ADMINISTRATION, ORAL; ADULT; ANTI-ARRHYTHMIA AGENTS; ANTIOXIDANTS; AREA UNDER CURVE; BEVERAGES; BIOLOGICAL AVAILABILITY; CALCIUM CHANNEL BLOCKERS; CITRUS; CROSS-OVER STUDIES; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; FELODIPINE; FLAVANONES; FLAVONOIDS; FOOD-DRUG INTERACTIONS; HUMANS; MALE; MIXED FUNCTION OXYGENASES; PSORALENS; REFERENCE VALUES;

EID: 0031711059     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(98)90173-4     Document Type: Article

References (24)

1. Bailey DG, Arnold JMO, Spence JD. Grapefruit juice and drugs: how significant is the interaction? Clin Pharmacokinet 1994;26:91-8.
2. Ameer B, Weintraub RA. Drug interactions with grapefruit juice. Clin Pharmacokinet 1997;33:103-21.
3. Bailey DG, Spence JD, Munoz C, Arnold JMO. Interaction of citrus juices with felodipine and nifedipine. Lancet 1991;337:268-9.
4. Edgar B, Regardh CG, Johnsson G, Johansson L, Lundborg P, Lofberg I, et al. Felodipine kinetics in healthy men. Clin Pharmacol Ther 1985;38:205-11.
5. Guengerich FP, Brian WR, Iwasaki M, Sari MA, Baarnhielm C, Berntsson P. Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P450IIIA4. J Med Chem 1991;34:1834-44.
6. Bailey DG, Bend JR, Arnold JMO, Tran LT, Spence JD. Erythromycin-felodipine interaction: magnitude, mechanism, and comparison with grapefruit juice. Clin Pharmacol Ther 1996;60:25-33.
7. Kolars JC, Schmiedlin-Rem P, Schuetz JD, Fang C, Watkins PB. Identification of rifampicin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. J Clin Invest 1992;90:1871-8.
8. Bailey DG, Arnold JMO, Bend JR, Tran LT, Spence JD. Grapefruit juice-felodipine interaction: reproducibility and characterization with the extended release drug formulation. Br J Clin Pharmacol 1995;40:135-40.
9. Lown KS, Bailey DG, Fontana RJ, Janardan SK, Adair CH, Fortlage LA, et al. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression [see comments]. J Clin Invest 1997;99:2545-53.
10. Lundahl J, Regardh CG, Edgar B, Johnsson G. Effects of grapefruit juice ingestion: pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men. Eur J Clin Pharmacol 1997;52: 139-45.
11. Edwards DJ, Bellevue FH, Woster PM. Identification of 6′,7′-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice. Drug Metab Dispos 1996;24:1287-90.
12. 1 activation in human liver microsomes by naringenin and other flavonoids. Carcinogenesis 1990;11:2275-9.
13. Miniscalco A, Lundahl J, Regardh CG, Edgar B, Eriksson UG. Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice. J Pharmacol Exp Ther 1992;261:1196-9.
14. Bailey DG, Arnold JMO, Munoz C, Spence JD. Grapefruit juice-felodipine interaction: mechanism, predictability and effect of naringin. Clin Pharmacol Ther 1993;53:637-42.
15. Bailey DG, Arnold JMO, Strong HA, Munoz C, Spence JD. Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics. Clin Pharmacol Ther 1993;54:589-94.
16. Ahnoff M. Determination of felodipine in plasma by capillary gas chromatography with electron capture detection. J Pharmacol Biomed Anal 1984;2:519-26.
17. Buening MK, Chang RL, Huang MT, Fortner JG, Wood AW, Conney AH. Activation and inhibition of benzo(a)pyrene and aflatoxin B-1 metabolism in human liver microsomes by naturally occurring flavonoids. Cancer Res 1981;41:67-72.
18. Kuhnau J. The flavonoids: a class of semi-essential food components; their role in human nutrition. World Rev Nutr Diet 1976;24:117-91.
19. Fuhr U, Kummert AL. The fate of naringin in humans: a key to grapefruit juice-drug interactions? Clin Pharmacol Ther 1995;58:365-73.
20. Cai Y, Bennett D, Nair RV, Ceska O, Ashwood-Smith MJ, DiGiovanni J. Inhibition and inactivation of murine hepatic ethoxy- and pentoxyresorufin O-dealkylase by naturally occurring coumarins. Chem Res Toxicol 1993;6:872-9.
21. Gray AI. Structural diversity and distribution of coumarins and chromones in the rutales. In: Waterman PG, Grundon MF, editors. Chemistry and chemical taxonomy of the rutales. London: Academic Press; 1983. p. 97-146.
22. He K, Iyer KR, Hayes RN, Sinz MW, Woolf TF, Hollenberg PF. Inactivation of cytochrome P450 3A4 by bergamottin, a component in grapefruit juice. Chem Res Toxicol 1998;11:252-9.
23. Schmiedlin-Ren P, Edwards DJ, Fitzsimmons ME, He K, Lown KS, Woster PM, et al. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit juice constituents: decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocourmarins. Drug Metab Dispos 1997;25:1228-33.
24. Fukuda K, Ohta T, Oshima Y, Ohashi N, Yoshikawa M, Yamazoe Y. Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction. Pharmacogenetics 1997;5:391-6.